Supporting the role of UCP3 in diabetes, drugs for diabetes treatment can restore the expression of UCP3 mRNA in skeletal muscle of patients with T2DM and impaired glucose tolerance [21, 22]. This evidence concerns the gene UCP3 and diabetes mellitus.